Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab in Metastatic Melanoma
NCT01376713Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2011
- Primary completion
- Jan 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in melanoma, sponsored by Medical University of Vienna. Started Jun 2011; status: completed.
02
Drugs
ofatumumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01376713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376713.